A detailed history of Bell Asset Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Bell Asset Management LTD holds 16,881 shares of AMGN stock, worth $5.33 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
16,881
Previous 20,280 16.76%
Holding current value
$5.33 Million
Previous $5.84 Million 17.84%
% of portfolio
0.71%
Previous 0.89%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $913,889 - $1.1 Million
-3,399 Reduced 16.76%
16,881 $4.8 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $2.41 Million - $2.72 Million
-9,435 Reduced 31.75%
20,280 $5.84 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $3.52 Million - $4.36 Million
-16,077 Reduced 35.11%
29,715 $7.99 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $17,784 - $21,029
-83 Reduced 0.18%
45,792 $10.2 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $4.77 Million - $5.81 Million
21,126 Added 85.36%
45,875 $11.1 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $1.88 Million - $2.39 Million
-8,212 Reduced 24.91%
24,749 $6.5 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $107,965 - $121,765
-481 Reduced 1.44%
32,961 $7.43 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $3.21 Million - $3.57 Million
-13,900 Reduced 29.36%
33,442 $8.14 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $52,186 - $57,731
-238 Reduced 0.5%
47,342 $11.4 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $71,000 - $81,253
357 Added 0.76%
47,580 $10.7 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $4.61 Million - $5.4 Million
21,709 Added 85.09%
47,223 $10 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $20,321 - $22,545
-87 Reduced 0.34%
25,514 $6.22 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $376,359 - $438,585
-1,696 Reduced 6.21%
25,601 $6.37 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $280,861 - $334,455
1,298 Added 4.99%
27,297 $6.28 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $598,826 - $665,944
2,552 Added 10.88%
25,999 $6.61 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $1.73 Million - $2.12 Million
8,732 Added 59.34%
23,447 $5.53 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $107,521 - $142,603
590 Added 4.18%
14,715 $2.98 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $3.02 Million - $3.88 Million
-15,941 Reduced 53.02%
14,125 $3.41 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $596,152 - $714,314
-3,424 Reduced 10.22%
30,066 $5.82 Million
Q1 2019

Apr 11, 2019

BUY
$180.87 - $203.88 $256,292 - $288,897
1,417 Added 4.42%
33,490 $6.36 Million
Q4 2018

Jan 22, 2019

SELL
$178.4 - $208.25 $14,807 - $17,284
-83 Reduced 0.26%
32,073 $6.24 Million
Q3 2018

Oct 29, 2018

SELL
$185.29 - $208.89 $302,763 - $341,326
-1,634 Reduced 4.84%
32,156 $6.67 Million
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $41,844 - $47,000
252 Added 0.75%
33,790 $6.25 Million
Q1 2018

Apr 30, 2018

BUY
$169.43 - $198.0 $11,351 - $13,266
67 Added 0.2%
33,538 $7.45 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $5.65 Million - $6.31 Million
33,471
33,471 $5.82 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bell Asset Management LTD Portfolio

Follow Bell Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bell Asset Management LTD with notifications on news.